on September 6, 2021 Categories COVID-19InflammationPediatricSars-Cov-2 DateSeptember 6, 2021 Frontiers in Pediatrics 06 September 2021 Share Related postsOctober 14, 2020Microvascular dysfunction in COVID-19: the MYSTIC studyRead moreAugust 18, 2020Tocilizumab improves oxidative stress and endothelial glycocalyx: A mechanism that may explain the effects of biological treatment on COVID-19Read moreDecember 31, 2020Vascular Endothelial Glycocalyx Damage in COVID-19Read more